Tilray | TRLY - Trade Debtors


Tilray reported $109.07M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Aurora Cannabis CAD 48.26M 1.53M Dec/2025
Avita Medical AUD 9.11M 2.26M Dec/2025
Canopy Growth CAD 140.42M 113.56M Dec/2025
Cronos Group USD 73.17M 4.87M Mar/2026
Dianthus Therapeutics USD 52K 4.95M Dec/2025
Divis Laboratories Ltd INR 29.99B 3.71B Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
IQVIA Holdings USD 3.38B 52M Mar/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Moderna USD 71M 113M Mar/2026
Organigram Holdings CAD 49.94M 14.92M Dec/2025
Organon & Co USD 1.33B 153M Dec/2025
Revvity USD 691.38M 53.29M Mar/2026
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 109.07M 2M Sep/2025
Viatris USD 3.08B 45M Mar/2026
Xeris Pharmaceuticals USD 51.05M 2.7M Dec/2025
Zealand Pharma A/S 340M 94.1M Dec/2025